<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101300215</journal-id>
<journal-id journal-id-type="pubmed-jr-id">33297</journal-id>
<journal-id journal-id-type="nlm-ta">Dev Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Dev Neurobiol</journal-id>
<journal-title-group>
<journal-title>Developmental neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1932-8451</issn>
<issn pub-type="epub">1932-846X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30304576</article-id>
<article-id pub-id-type="pmc">6397659</article-id>
<article-id pub-id-type="doi">10.1002/dneu.22645</article-id>
<article-id pub-id-type="manuscript">NIHMS1013944</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Disruption of MET Receptor Tyrosine Kinase, an Autism Risk Factor, Impairs Developmental Synaptic Plasticity in the Hippocampus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Xiaokuang</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7900-6779</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Ke</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Zhongming</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Piechowicz</surname>
<given-names>Mariel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Qiang</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Shenfeng</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0730-1602</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona 85004</aff>
<aff id="A2"><label>2</label>Barrow Neurological Institute, St. Joseph’s Hospital Medical Center, Phoenix, Arizona 85013</aff>
<aff id="A3"><label>3</label>Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, 515041, China</aff>
<aff id="A4"><label>4</label>MOE Key Laboratory for NeuroInformation, The Clinical Hospital of Chengdu Brain Sciences Institute, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610054, China</aff>
<author-notes>
<corresp id="CR1"><italic>Correspondence to</italic>: S. Qiu (<email>sqiu@email.arizona.edu</email>)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>79</volume>
<issue>1</issue>
<fpage>36</fpage>
<lpage>50</lpage>
<!--elocation-id from pubmed: 10.1002/dneu.22645-->
<abstract id="ABS1">
<p id="P1">As more genes conferring risks to neurodevelopmental disorders are identified, translating these genetic risk factors into biological mechanisms that impact the trajectory of the developing brain is a critical next step. Here, we report that disrupted signaling mediated MET receptor tyrosine kinase (RTK), an established risk factor for autism spectrum disorders, in the developing hippocampus glutamatergic circuit leads to profound deficits in neural development, synaptic transmission, and plasticity. In cultured hippocampus slices prepared from neonatal mice, pharmacological inhibition of MET kinase activity suppresses dendritic arborization and disrupts normal dendritic spine development. In addition, single-neuron knockdown (RNAi) or overexpression of <italic>Met</italic> in the developing hippocampal CA1 neurons leads to alterations, opposite in nature, in basal synaptic transmission and long-term plasticity. In forebrain-specific <italic>Met</italic> conditional knockout mice (<italic>Met</italic><sup>fx/fx</sup>;<italic>emx1</italic><sup>cre</sup>), an enhanced long-term potentiation (LTP) and long-term depression (LTD) were observed at early developmental stages (P12–14) at the Schaffer collateral to CA1 synapses compared with wild-type littermates. In contrast, LTP and LTD were markedly reduced at young adult stage (P56–70) during which wild-type mice show robust LTP and LTD. The altered trajectory of synaptic plasticity revealed by this study indicate that temporally regulated MET signaling as an intrinsic, cell autonomous, and pleiotropic mechanism not only critical for neuronal growth and functional maturation, but also for the timing of synaptic plasticity during forebrain glutamatergic circuits development.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>hippocampus</kwd>
<kwd>MET receptor tyrosine kinase</kwd>
<kwd>neurodevelopment</kwd>
<kwd>synaptic plasticity</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>